Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sun-Powered clothing could ease psoriasis and hair loss

NCT ID NCT05391178

Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested special clothing made with Lumiton yarn that captures sunlight and turns it into red and near-infrared light, aiming to improve skin conditions like psoriasis, alopecia areata, and polymorphous light eruption. Eighteen adults with mild-to-severe forms of these conditions wore the garments and were monitored for changes in disease severity. The approach is designed to be a more convenient and affordable alternative to traditional phototherapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lumiton yarn clothing (sleeves, hats, shirts) that harnesses sunlight to produce red and near-infrared light
What this could lead to
If it works, this could offer a more accessible, low-cost way to manage skin conditions like psoriasis and alopecia areata without expensive clinic visits.
What could go wrong
This was a very small, early study with only 18 people and no control group, so results may not be reliable or apply to everyone. The technology depends on sunlight, which may not be available in all climates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Aug 2022

Finished

May 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult participants ≥18 years of age * Participants who live in the US, * Participants who are diagnosed with mild-to-severe AA, PMLE, or psoriasis * Participants have sufficient command of the English language Exclusion Criteria: * Participants less than the age of 18 * Participants who do not live in the US * Participants who are not diagnosed with mild to severe AA, PMLE, or psoriasis * Participants without a sufficient command of the English language * Participants with concurrent medical conditions that are at risk of confounding the study outcomes * Participants currently using concomitant phototherapy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alopecia areata are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia areata polymorphic light eruption psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alopecia areata Polymorphous light eruption Psoriasis

Contacts and locations

Locations

  • Wake Forest University Health Sciences, Dermatology

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.